AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion April 15, 2024 For any parent, learning after delivery that their baby may have a serious chromosomal condition can be heartbreaking and scary. Unfortunately, some conditions... Continue Reading
Rare Diseases: Pathways to accelerating diagnoses March 13, 2024 Many of us have seen stories in the news about American families on diagnostic odysseys for their children with rare diseases. Recently, the Today Show highlig... Continue Reading
Maternal Health Is in Crisis. We Need to Change That Right Now. August 29, 2022 By Melissa Gonzales, president of Women's Health According to the World Health Organization, the U.S. is one of the most dangerous places in the world for a... Continue Reading
New Enhancements to Noninvasive Prenatal Screening (NIPS) March 21, 2022 Myriad Genetics was honored to participate in one of the most important conferences for Maternal Fetal Medicine specialists and other medical providers focused... Continue Reading
The impact of prenatal screening on parents and pregnancies February 5, 2022 There are many factors to consider when developing a genetic test or screen. Some common examples include sensitivity, specificity, cost, and turnaround time. T... Continue Reading